BAXTER INTERNATIONAL INC. Debt Securities Underwriting Agreement Standard ProvisionsUnderwriting Agreement • August 23rd, 2018 • Baxter International Inc • Surgical & medical instruments & apparatus • New York
The terms and rights of any particular issue of Designated Securities shall be as specified in the Underwriting Agreement related thereto and in or pursuant to the indenture dated as of August 8, 2006, between the Company and The Bank of New York Mellon Trust Company, N.A. (as successor in interest to J.P. Morgan Trust Company, National Association) (the “Base Indenture”) and the supplemental indenture identified in the Underwriting Agreement (the “Supplemental Indenture,” and together with the Base Indenture, the “Indenture”). The obligation of the Company to issue and sell any of the Designated Securities and the obligation of the Underwriters to purchase any of the Designated Securities shall be evidenced by the Underwriting Agreement with respect to the Designated Securities specified therein.
